Denosumab for bone metastases from breast cancer: a new therapy option?
- PMID: 21464408
- DOI: 10.1200/JCO.2010.33.9150
Denosumab for bone metastases from breast cancer: a new therapy option?
Comment on
-
Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study.J Clin Oncol. 2010 Dec 10;28(35):5132-9. doi: 10.1200/JCO.2010.29.7101. Epub 2010 Nov 8. J Clin Oncol. 2010. PMID: 21060033 Clinical Trial.
-
Denosumab: second chapter in controlling bone metastases or a new book?J Clin Oncol. 2010 Dec 10;28(35):5127-31. doi: 10.1200/JCO.2010.31.0128. Epub 2010 Nov 8. J Clin Oncol. 2010. PMID: 21060038 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical